出来高 | 10,134 |
|
|||||
ニュース | - | ||||||
今日の高値 | 1.71 | 安値 高値 |
|||||
今日の安値 | 1.63 |
企業情報 - Oragenics Inc
時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
---|---|---|---|---|---|---|
0 | 2.57M | - | 38k | -20.66M | - | - |
Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ニュース - Oragenics
日付 | 時間 | 情報元 | タイトル |
---|---|---|---|
2024/5/23 | 22:27 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/22 | 21:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/22 | 21:00 | GlobeNewswire Inc. | Oragenics Appoints William “Frank” Peacock MD as Chief.. |
2024/5/17 | 21:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/17 | 21:00 | GlobeNewswire Inc. | Oragenics, Inc. to Host Webinar Panel on Neurotrauma.. |
2024/5/16 | 21:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/16 | 21:00 | GlobeNewswire Inc. | Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002,.. |
2024/5/16 | 02:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2024/5/07 | 21:14 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/07 | 21:00 | GlobeNewswire Inc. | Oragenics Partners with Avance Clinical for Phase II.. |
2024/4/20 | 06:50 | Business Wire | Oragenics, Inc. Announces Notification of Noncompliance with.. |
2024/4/01 | 22:05 | Business Wire | Oragenics, Inc. Files 10K and Provides Company Update |
チャート - Oragenics
期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
---|---|---|---|---|---|---|---|
1週 | 1.70 | 2.02 | 1.6263 | 1.70 | 32,943 | -0.06 | -3.53% |
1ヶ月 | 1.60 | 3.43 | 1.50 | 2.64 | 171,306 | 0.04 | 2.50% |
3ヶ月 | 1.44 | 3.43 | 1.00 | 2.00 | 113,843 | 0.20 | 13.89% |
6ヶ月 | 4.96 | 7.74 | 1.00 | 2.09 | 94,611 | -3.32 | -66.94% |
1年 | 2.99 | 7.74 | 1.00 | 2.28 | 54,106 | -1.35 | -45.15% |
3年 | 47.40 | 69.00 | 1.00 | 36.94 | 1,037,267 | -45.76 | -96.54% |
5年 | 30.60 | 127.20 | 1.00 | 49.80 | 3,060,658 | -28.96 | -94.64% |